{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-089150","form_type":"8-K","ticker":"ARMP","cik":"0000921114","company_name":"Armata Pharmaceuticals, Inc.","filed_at":"2025-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.705912+00:00","generated_at":"2026-05-17T06:56:56.204250+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Armata presents at H.C. Wainwright conference; no new data in exhibit","bullets":["CEO Dr. Deborah Birx presented at H.C. Wainwright 27th Annual Global Investment Conference on Sept 10, 2025.","Exhibit 99.1 contains only title slide and forward-looking disclaimers; no new clinical or financial data.","Prior $26.2M DoD award referenced in disclaimers; no update on program milestones or guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-089150","json":"https://secwatch.observer/filing/0001104659-25-089150.json","markdown":"https://secwatch.observer/filing/0001104659-25-089150.md","text":"https://secwatch.observer/filing/0001104659-25-089150.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/921114/000110465925089150/0001104659-25-089150-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/921114/000110465925089150/tm2525814d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:56:56.204250+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}